EPO

EPO

Target · Cytokine hormone

EPO Erythropoietin · EP

EPO (erythropoietin, alias EP) is a secreted, glycosylated cytokine and hormone that regulates erythrocyte proliferation and differentiation. It is mainly made in the kidney and signals through the erythropoietin receptor to support red blood cell production. Browse Assay Genie's current range of EPO research reagents below, or read on for the biology behind the target.

Secreted glycoproteinBinds EPOR, activates JAK2Upregulated by hypoxia
193 aa
Protein length
~21 kDa
Molecular weight
7q22.1
Gene locus
EPO/TPO family
Protein family
Target information

What is EPO (erythropoietin)?

EPO is a hormone involved in the regulation of erythrocyte proliferation and differentiation and in the maintenance of a physiological level of circulating erythrocyte mass. It binds to EPOR, the erythropoietin receptor, leading to EPOR dimerisation and activation of JAK2. This in turn activates specific downstream effectors, including STAT1 and STAT3. In the bone marrow, this signalling promotes red blood cell production, or erythropoiesis.

The EPO gene encodes a secreted, glycosylated cytokine composed of four alpha helical bundles, and the protein belongs to the EPO/TPO family. HGNC classifies it among receptor ligands. The protein is mainly synthesised in the kidney and secreted into the blood plasma. Expression of the gene is upregulated under hypoxic conditions, which increases erythropoiesis and enhances the oxygen-carrying capacity of the blood. Mouse and rat orthologs are both designated Epo, which is useful when planning comparative work.

Expression has also been observed in the brain and the eye, and elevated levels have been reported in diabetic retinopathy and ocular hypertension. Recombinant forms of the protein show neuroprotective activity against a variety of potential brain injuries, as well as antiapoptotic functions in several tissue types. Recombinant EPO has been used in the treatment of anaemia and to enhance the efficacy of cancer therapies, so researchers studying EPO protein levels, EPO gene regulation or EPOR signalling work across haematology, oncology and neuroscience.

Erythropoiesis and haematology

EPO regulates erythrocyte proliferation and differentiation and helps maintain circulating erythrocyte mass, making it central to studies of red blood cell production.

Hypoxia response

EPO expression is upregulated under hypoxic conditions, increasing erythropoiesis and the oxygen-carrying capacity of the blood.

Neuroprotection and apoptosis

Recombinant EPO shows neuroprotective activity against several brain injuries and antiapoptotic functions in a range of tissue types.

Ocular and cancer research

EPO is elevated in diabetic retinopathy and ocular hypertension, and recombinant forms have been used to enhance the efficacy of cancer therapies.

Background

EPO frequently asked questions

What does EPO do?

EPO is a secreted hormone that regulates erythrocyte proliferation and differentiation. It binds EPOR, causing receptor dimerisation and JAK2 activation, which activates downstream effectors including STAT1 and STAT3. The result is increased red blood cell production in the bone marrow.

What are the alternative names for EPO?

EPO is the HGNC symbol for erythropoietin, and EP is listed as an alias. UniProt names the protein Erythropoietin and places it in the EPO/TPO family. HGNC lists no previous names for the gene.

Is EPO conserved in mouse and rat?

Yes. Both mouse and rat have an ortholog named Epo. Human EPO is a secreted, glycosylated cytokine made mainly in the kidney, so check the datasheet of any product for its validated reactivity before using it in rodent models.

Explore

Related targets

Receptor, kinase and transcription factor partners in EPO signalling, plus the related EPO/TPO family member thrombopoietin.

Gene and protein annotations from HGNC, NCBI Gene and UniProt P01588; product specifications from Assay Genie datasheets.

EPO Product listing